ZA909568B - Stabilized solutions of psychotropic agents - Google Patents
Stabilized solutions of psychotropic agentsInfo
- Publication number
- ZA909568B ZA909568B ZA909568A ZA909568A ZA909568B ZA 909568 B ZA909568 B ZA 909568B ZA 909568 A ZA909568 A ZA 909568A ZA 909568 A ZA909568 A ZA 909568A ZA 909568 B ZA909568 B ZA 909568B
- Authority
- ZA
- South Africa
- Prior art keywords
- stabilized
- methionine
- psychotropic agents
- stabilized solutions
- septiline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP89203092 | 1989-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA909568B true ZA909568B (en) | 1991-09-25 |
Family
ID=8202518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA909568A ZA909568B (en) | 1989-12-06 | 1990-11-28 | Stabilized solutions of psychotropic agents |
Country Status (15)
Country | Link |
---|---|
US (1) | US5082864A (es) |
EP (1) | EP0431663B1 (es) |
JP (1) | JP2977912B2 (es) |
KR (1) | KR0185377B1 (es) |
AT (1) | ATE99943T1 (es) |
AU (1) | AU628768B2 (es) |
CA (1) | CA2030773C (es) |
DE (1) | DE69005992T2 (es) |
DK (1) | DK0431663T3 (es) |
ES (1) | ES2062310T3 (es) |
FI (1) | FI97689C (es) |
IE (1) | IE63985B1 (es) |
NZ (1) | NZ236332A (es) |
PT (1) | PT96096B (es) |
ZA (1) | ZA909568B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USH1591H (en) * | 1992-10-09 | 1996-09-03 | Fulcher; John | Preparation of flavor-enhanced reduced calorie fried foods |
IL107887A (en) * | 1992-12-08 | 2003-07-06 | Ambi Inc | Stabilized lanthionine containing bacteriocin compositions |
US6197830B1 (en) | 1995-09-22 | 2001-03-06 | Bruce M. Frome | Method for achieving relief from sympathetically mediated pain |
EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
IL123716A (en) * | 1997-03-27 | 2001-03-19 | Akzo Nobel Nv | Therapeutic combinations of mirtazapine and an antipsychotic agent |
WO1999051237A1 (en) * | 1998-04-02 | 1999-10-14 | Akzo Nobel N.V. | Oral liquid antidepressant solution |
US6211171B1 (en) | 1998-05-19 | 2001-04-03 | Dalhousie University | Use of antidepressants for local analgesia |
US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
JP2004532190A (ja) * | 2001-02-12 | 2004-10-21 | アクゾ・ノベル・エヌ・ベー | アポリポタンパク質e4の遺伝子の遺伝子型決定により大うつ病の治療を改善するための方法 |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
ATE388698T1 (de) | 2003-04-29 | 2008-03-15 | Orexigen Therapeutics Inc | Zusammensetzungen zur beeinflussung des gewichtsverlusts |
US7838029B1 (en) | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
WO2005070461A2 (en) * | 2004-01-13 | 2005-08-04 | Duke University | Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss |
US20060039866A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
US20060058390A1 (en) * | 2004-09-14 | 2006-03-16 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
WO2006055854A2 (en) * | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
PT2135603E (pt) | 2005-11-22 | 2013-04-03 | Orexigen Therapeutics Inc | Composições e métodos para aumentar a sensibilidade à insulina |
AU2007207606A1 (en) * | 2006-01-17 | 2007-07-26 | Regents Of The University Of Colorado | Central administration of stable formulations of therapeutic agents for CNS conditions |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
JP2010509367A (ja) | 2006-11-09 | 2010-03-25 | オレキシジェン・セラピューティクス・インコーポレーテッド | 積層製剤 |
KR20090090316A (ko) | 2006-11-09 | 2009-08-25 | 오렉시젠 세러퓨틱스 인크. | 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법 |
EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
JP2011521973A (ja) * | 2008-05-30 | 2011-07-28 | オレキシジェン・セラピューティクス・インコーポレーテッド | 内臓脂肪の状態を処置するための方法 |
KR20120124423A (ko) | 2010-01-11 | 2012-11-13 | 오렉시젠 세러퓨틱스 인크. | 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법 |
PT3730132T (pt) | 2012-06-06 | 2022-08-16 | Nalpropion Pharmaceuticals Llc | Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular |
KR101652081B1 (ko) | 2014-12-30 | 2016-08-30 | 김인호 | 전극보일러 급탕시스템 |
EP3261645B1 (en) | 2015-02-27 | 2021-04-28 | Dechra Limited | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
KR20170001494A (ko) | 2015-06-26 | 2017-01-04 | 김인호 | 전극보일러 전류제어시스템 |
CN108853042B (zh) * | 2018-09-20 | 2021-03-26 | 北京哈三联科技有限责任公司 | 一种米氮平冻干口崩片及其制备方法和应用 |
GR1009883B (el) * | 2019-06-07 | 2020-12-11 | Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. | Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν υδροχλωρικη νορτριπτυλινη |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2082910A (en) * | 1980-08-28 | 1982-03-17 | Berk Pharmaceuticals Ltd | Anti-depressant compositions |
US4603131A (en) * | 1982-04-26 | 1986-07-29 | Bernstein Joel E | Method and composition for treating and preventing irritation of the mucous membranes of the nose |
DE3247676A1 (de) * | 1982-12-23 | 1984-06-28 | A. Nattermann & Cie GmbH, 5000 Köln | Galenische form fuer amitriptylinoxid und verfahren zur herstellung |
-
1990
- 1990-11-20 DK DK90203064.2T patent/DK0431663T3/da active
- 1990-11-20 EP EP90203064A patent/EP0431663B1/en not_active Expired - Lifetime
- 1990-11-20 ES ES90203064T patent/ES2062310T3/es not_active Expired - Lifetime
- 1990-11-20 DE DE90203064T patent/DE69005992T2/de not_active Expired - Lifetime
- 1990-11-20 AT AT90203064T patent/ATE99943T1/de not_active IP Right Cessation
- 1990-11-22 IE IE422690A patent/IE63985B1/en not_active IP Right Cessation
- 1990-11-23 CA CA002030773A patent/CA2030773C/en not_active Expired - Fee Related
- 1990-11-28 ZA ZA909568A patent/ZA909568B/xx unknown
- 1990-12-03 US US07/621,480 patent/US5082864A/en not_active Expired - Lifetime
- 1990-12-04 NZ NZ236332A patent/NZ236332A/en unknown
- 1990-12-05 AU AU67798/90A patent/AU628768B2/en not_active Ceased
- 1990-12-05 KR KR1019900019904A patent/KR0185377B1/ko not_active IP Right Cessation
- 1990-12-05 PT PT96096A patent/PT96096B/pt not_active IP Right Cessation
- 1990-12-05 FI FI906008A patent/FI97689C/fi active IP Right Grant
- 1990-12-06 JP JP2413592A patent/JP2977912B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU6779890A (en) | 1991-06-13 |
ES2062310T3 (es) | 1994-12-16 |
ATE99943T1 (de) | 1994-01-15 |
CA2030773A1 (en) | 1991-06-07 |
US5082864A (en) | 1992-01-21 |
CA2030773C (en) | 2001-07-24 |
IE904226A1 (en) | 1991-06-19 |
EP0431663B1 (en) | 1994-01-12 |
FI906008A0 (fi) | 1990-12-05 |
DE69005992D1 (de) | 1994-02-24 |
IE63985B1 (en) | 1995-06-28 |
JP2977912B2 (ja) | 1999-11-15 |
PT96096B (pt) | 1998-02-27 |
KR910011250A (ko) | 1991-08-07 |
DK0431663T3 (da) | 1994-03-07 |
FI97689B (fi) | 1996-10-31 |
EP0431663A1 (en) | 1991-06-12 |
JPH05262651A (ja) | 1993-10-12 |
KR0185377B1 (ko) | 1999-05-01 |
FI97689C (fi) | 1997-02-10 |
AU628768B2 (en) | 1992-09-17 |
DE69005992T2 (de) | 1994-05-05 |
NZ236332A (en) | 1992-07-28 |
PT96096A (pt) | 1991-09-30 |
FI906008A (fi) | 1991-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA909568B (en) | Stabilized solutions of psychotropic agents | |
ATE176752T1 (de) | Mischkapsel für dentalmassen | |
DE69629209D1 (de) | Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose | |
DE3686410D1 (de) | Stabilisierte zusammensetzungen von menschlichen aktivatoren des gewebeplasminogens. | |
DK0675717T3 (da) | Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin | |
EE9500015A (et) | Meetod pranoprofeeni stabiliseerimiseks ja pranoprofeeni stabiilne vedelpreparaat | |
DK0688771T3 (da) | Anvendelse af lactamforbindelser som farmaceutiske aktivstoffer | |
ATE86970T1 (de) | 2-substituierte paraaminophenole und ihre verwendung fuer die faerbung von keratinischen fasern. | |
GB2000970A (en) | Injectable chloramphenicol composition | |
ATE118209T1 (de) | Pyridin-3-percarboxylsäure monopersulfat. | |
SE7514294L (sv) | 4,4'-bis-/2",4"-bis-(diisopropanolamino)-s-triazin-6"-ylamino/-stilben-2,2'-disulfonsyra, dess framstellning och dess anvendning som optiskt vithetsforhojande medel | |
IL81681A (en) | Stable pharmaceutical formulation of 1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)-ethylamino)anthraquinone,dihydrochloride | |
DK0506659T3 (da) | Tandtråd med kemoterapeutiske midler. | |
DE3667472D1 (de) | Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen. | |
IL96299A (en) | Aminomethyl-3-(1- carboxycyclopentyl) propanoic acid derivatives and their preparation | |
FI903950A0 (fi) | Ny komposition. | |
DK0925785T3 (da) | Stabiliseret farmaceutisk præparat indeholdende dopamin eller dobutamin | |
DE69004138T2 (de) | Mit einer Cyanogruppe substituierte Nitroanilin-Farbstoffe. |